AGARWALEYE logo

DR Agarwals Health CARE L

AGARWALEYE·NSE·
517.60 +8.90 (+1.75%)
Market Cap16124.93 Cr
PE Ratio123.24
Volume2,51,047
Day High - Low524.50 - 508.15
52W High-Low568.00 - 401.00
DocStoX Score
5.6/10
Fair
Fair Value
Sign in to see
ROE
6.81%
Weak
P/E
123.24x
Expensive
Debt / Equity
0.34
Moderate
Industry
Healthcare
Hospital
Overall View
Mixed

Price performance

Day508.15
524.50
52W401.00
568.00
DocStoX take

Supported by growth (7.7) and risk (7.5), but held back by valuation (0.0). Growth looks strong at 7.7, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.6
/10
Fair
Quality
Solid
ROE 6.8%
Valuation
Expensive
P/E 123.2×
Growth
Strong
Revenue +34.6% 5Y CAGR
Risk
Low risk
D/E 0.34
Momentum
Strong
70% of 52-week range

At a glance

Market Cap
₹16,125 Cr
52W High / Low
₹568 / ₹401
Dividend Yield
0.00%
Promoter Holding
32.34%
EPS (TTM)
₹4.20
Book Value
₹63.90

Key highlights

  • Revenue compounding 35% a year
  • Profitable in all of the last 5 years
  • Profit compounding 18% a year
  • Valuation is weak (0.0/10)
  • Expensive at 123× earnings
3 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Hospital

DR AGARWALS HEALTH CARE L peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.